Edition:
United States

Guided Therapeutics Inc (GTHP.OB)

GTHP.OB on OTC BB

0.02USD
12 Dec 2017
Change (% chg)

$-0.00 (-13.09%)
Prev Close
$0.03
Open
$0.03
Day's High
$0.03
Day's Low
$0.02
Volume
1,926,658
Avg. Vol
1,086,978
52-wk High
$2.12
52-wk Low
$0.01

Chart for

About

Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices. The Company's primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including... (more)
No analyst recommendations are available for .

Overall

Beta: 0.05
Market Cap(Mil.): $0.10
Shares Outstanding(Mil.): 3.60
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 28.30 15.71
EPS (TTM): -- -- --
ROI: -- 10.04 31.93
ROE: -- 15.26 16.16

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $57.07 +0.73
GlaxoSmithKline plc (GSK.L) 1,314.50 --
Hologic, Inc. (HOLX.OQ) $43.57 -0.25
Qiagen NV (QGEN.OQ) $31.67 +0.41
SpectraScience Inc (SCIE.PK) $0.00 -0.00

Earnings vs. Estimates

No consensus analysis data available.